The Atellica IM High-Sensitivity Troponin I assay expands capabilities in cardiac care
The first cleared troponin assay in the U.S. for longer-term prognostic insights
The first cleared troponin assay in the U.S. for longer-term prognostic insights
The INNOVANCE Anti-Xa assay for anticoagulant therapy management delivers fully automated, ready-to-use testing for heparins, rivaroxaban, apixaban, and edoxaban
Discover how Siemens Healthineers is breaking down barriers and making automation more accessible, efficient, and beneficial for clinical labs of all sizes
This high-sensitivity troponin test from Siemens Healthineers is the only one in the US with a prognostic risk intended use
Discover how sustainability, efficiency, automation and other trends are impacting diagnostic innovation and improving healthcare outcomes
Optimism that automation and AI will help tackle challenges
At the ADLM 2024 Clinical Lab Expo (July 28–August 1, Chicago, Booth #501), Siemens Healthineers will demonstrate what is achievable for laboratory testing with human-centered engineering and automation.
NT‑proBNPII Assay now part of Atellica cardiac testing menu
Professor of Emergency Medicine at the University of Manchester highlights the promise of point-of-care high-sensitivity troponin assays in the emergency department
New blood test developed by Siemens Healthineers in collaboration with Novartis aims to improve the management of MS
The Anti-Müllerian Hormone Assay reveals a patient's ovarian reserve information
The new compact testing system is designed to tackle a range of challenges faced by today's laboratories
Removes workflow barriers to improve patient care
Rapid antigen testing provides results in just 15 minutes and the information can help reduce the risk of COVID-19 exposure
The lab-based Atellica and ADVIA Centaur SARS-CoV-2 Antigen Assays (CoV2Ag) are well designed to detect Omicron variant
The fully automated CN-3000 and CN-6000 Systems bring mid- and high-volume coagulation testing to laboratories
The company plans to interface the algorithm into the Atellica Data Manager software in the future
The catheter transforms care delivery by enabling access to structural heart procedures for patients with tricuspid regurgitation and other pathologies
The fast time-to-result includes a pretreatment process to inactivate the virus as a safeguard for laboratory staff handling the samples
As SARS-CoV-2 vaccines become available, Siemens Healthineers is ready with fully automated antibody tests that can be used to help inform whether broad vaccination programs are working
Easy-to-use test, which doesn't require specialized laboratory personnel or instruments, promises flexibility to test in locations that benefit from immediate results